Edition:
United States

Profile: Mesoblast Ltd (MSB.AX)

MSB.AX on Australia Stock Exchange

1.19AUD
5 Dec 2016
Change (% chg)

$-0.03 (-2.46%)
Prev Close
$1.22
Open
$1.22
Day's High
$1.22
Day's Low
$1.18
Volume
410,161
Avg. Vol
817,808
52-wk High
$3.03
52-wk Low
$1.01

Mesoblast Limited is engaged in developing cell-based medicines. The Company has leveraged its technology platform, which is based on specialized cells known as mesenchymal lineage adult stem cells, to establish a portfolio of late-stage product candidates. Its allogeneic, off-the-shelf cell product candidates target advanced stages of diseases with high, unmet medical needs, including cardiovascular conditions, orthopedic disorders, immunologic and inflammatory disorders and oncologic/hematologic conditions.

Company Address

Mesoblast Ltd

L 38 55 Collins St
MELBOURNE   VIC   3000
P: +613.96396036
F: +613.96396030

Company Web Links